- Report
- April 2024
- 125 Pages
Global
From €2843EUR$3,160USD£2,432GBP
€3554EUR$3,950USD£3,041GBP
- Report
- February 2024
- 140 Pages
Global
From €3059EUR$3,400USD£2,617GBP
€3823EUR$4,250USD£3,272GBP
- Report
- January 2024
- 143 Pages
Global
From €3059EUR$3,400USD£2,617GBP
€3823EUR$4,250USD£3,272GBP
- Report
- January 2022
- 120 Pages
Global
From €4273EUR$4,750USD£3,656GBP
- Report
- October 2023
- 146 Pages
Global
From €3733EUR$4,150USD£3,195GBP
From €1885EUR$2,095USD£1,613GBP
€3590EUR$3,990USD£3,071GBP
- Report
- June 2025
United Kingdom
From €1885EUR$2,095USD£1,613GBP
€3590EUR$3,990USD£3,071GBP
- Report
- July 2021
- 151 Pages
Europe
From €3104EUR$3,450USD£2,656GBP
- Report
- July 2021
- 148 Pages
Middle East, Africa
From €3104EUR$3,450USD£2,656GBP
- Report
- May 2024
- 67 Pages
Global
From €3144EUR$3,495USD£2,690GBP
- Report
- December 2023
- 78 Pages
Global
From €3144EUR$3,495USD£2,690GBP
- Report
- November 2023
- 1203 Pages
Global
From €2249EUR$2,500USD£1,924GBP
- Report
- January 2023
- 1469 Pages
Global
From €4498EUR$5,000USD£3,849GBP
- Report
- November 2022
- 244 Pages
Global
From €2249EUR$2,500USD£1,924GBP
- Report
- November 2022
- 624 Pages
Global
From €2249EUR$2,500USD£1,924GBP
- Report
- November 2022
- 107 Pages
Global
From €3554EUR$3,950USD£3,041GBP
- Report
- August 2022
- 70 Pages
Global
From €3144EUR$3,495USD£2,690GBP
- Report
- June 2022
- 62 Pages
Global
From €3144EUR$3,495USD£2,690GBP
- Report
- November 2021
- 108 Pages
Global
From €13490EUR$14,995USD£11,543GBP
- Report
- November 2018
- 30 Pages
Global
From €3594EUR$3,995USD£3,075GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more